| scholarly article | Q13442814 |
| P50 | author | Steven R. Little | Q42862882 |
| P2093 | author name string | William J Federspiel | |
| Sam N Rothstein | |||
| P2860 | cites work | Finite element analysis of the release of slowly dissolving drugs from cylindrical matrix systems | Q28186079 |
| Characterization of a homologous series of D,L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro | Q30805596 | ||
| The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices | Q34072262 | ||
| Mathematical modeling of bioerodible, polymeric drug delivery systems. | Q34258366 | ||
| Transport rates of proteins in porous materials with known microgeometry | Q34261133 | ||
| Polyanhydride degradation and erosion. | Q34971393 | ||
| Biodegradable microspheres for protein delivery | Q35184855 | ||
| Role of polyanhydrides as localized drug carriers. | Q36093677 | ||
| Biodegradable microspheres for parenteral delivery | Q36432726 | ||
| Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems | Q36649932 | ||
| Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release | Q38550816 | ||
| Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery. | Q40383064 | ||
| Mechanisms of polymer degradation and erosion | Q40983477 | ||
| How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment | Q47845144 | ||
| Why degradable polymers undergo surface erosion or bulk erosion. | Q52033945 | ||
| Investigation of the in vitro release of gentamicin from a polyanhydride matrix | Q73280986 | ||
| A theoretical model of erosion and macromolecular drug release from biodegrading microspheres | Q74017426 | ||
| A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations | Q78779013 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mathematical model | Q486902 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1657-1664 | |
| P577 | publication date | 2008-12-19 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices | |
| P478 | volume | 30 |
| Q36379675 | Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo |
| Q36768786 | Biomimetic delivery with micro- and nanoparticles |
| Q37735550 | Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine |
| Q36814280 | Biotargeted nanomedicines for cancer: six tenets before you begin |
| Q38967763 | Computational nanomedicine for mechanistic elucidation of bilayer nanoparticle-mediated release for tissue engineering. |
| Q35694277 | Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheres |
| Q91670923 | Data-Driven Development of Predictive Models for Sustained Drug Release |
| Q33902253 | Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. |
| Q37777061 | Designing Bioactive Delivery Systems for Tissue Regeneration |
| Q64114293 | Drug Delivery From Polymer-Based Nanopharmaceuticals-An Experimental Study Complemented by Simulations of Selected Diffusion Processes |
| Q30476025 | Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems |
| Q96353896 | Evaluation of the drug release kinetics in assembled modular systems based on the Dome Matrix technology |
| Q83745465 | Hyaluronan-based heparin-incorporated hydrogels for generation of axially vascularized bioartificial bone tissues: in vitro and in vivo evaluation in a PLDLLA-TCP-PCL-composite system |
| Q38116457 | IL-1Ra and its delivery strategies: inserting the association in perspective. |
| Q38325811 | In vitro characterization of a sustained-release formulation for enfuvirtide. |
| Q36456955 | Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review |
| Q42862823 | Microparticulate systems for targeted drug delivery to phagocytes |
| Q33726578 | Modeling of small-molecule release from crosslinked hydrogel microspheres: Effect of crosslinking and enzymatic degradation of hydrogel matrix |
| Q30544601 | Modeling vascularized bone regeneration within a porous biodegradable CaP scaffold loaded with growth factors |
| Q47442388 | Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation. |
| Q39846209 | PLGA erosion: solubility- or diffusion-controlled? |
| Q37515801 | Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells |
| Q38994544 | Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices. |
| Q37319692 | Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes |
| Q41232611 | Reaction-diffusion degradation model for delayed erosion of cross-linked polyanhydride biomaterials |
| Q58794823 | Scaffolds as Structural Tools for Bone-Targeted Drug Delivery |
| Q42158243 | Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis |
| Q42098676 | Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. |
| Q43298009 | Silica xerogel-chitosan nano-hybrids for use as drug eluting bone replacement |
| Q38253203 | Strategies to direct the enrichment, expansion, and recruitment of regulatory cells for the treatment of disease. |
| Q89968151 | Tuning Crystal Structures of Iron-Based Metal-Organic Frameworks for Drug Delivery Applications |
Search more.